Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Clinical and Experimental Medicine

Issue 2/2006

Content (9 Articles)

REVIEW

Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus

M. Reichlin

REVIEW

The molecular basis of coeliac disease

C. S. Hourigan

ORIGINAL

Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis?

R. Noakes, L. Spelman, R. Williamson

ORIGINAL

Expression and quantification of LYVE-1 in human colorectal cancer

F. Gao*, Y. M. Lu*, M. L. Cao*, Y. W. Liu, Y. Q. He, Y. Wang

ORIGINAL

Association of serum pepsinogen with atrophic body gastritis in Costa Rica

R. Sierra, C. Une, V. Ramírez, Ma. I González, J. A. Ramírez, A. de Mascarel, R. Barahona, R. Salas-Aguilar, R. Páez, G. Avendaño, A. Ávalos, N. Broutet, F. Mégraud

ORIGINAL

Ambroxol for the prevention of acute upper respiratory disease

K. Nobata, M. Fujimura, Y. Ishiura, S. Myou, S. Nakao

ORIGINAL

Role of superoxide dismutase in vascular inflammation and in coronary artery disease

V. Lubrano, P. Di Cecco, G. C. Zucchelli

ORIGINAL

The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in breast cancer

W. Jelski, L. Chrostek, M. Szmitkowski, W. Markiewicz

ORIGINAL

Acute effect of ionic high osmolar contrast medium on renal antioxidant enzyme activity in streptozotocin-induced diabetic rats

H.-W. Yen, H.-C. Lee, H.-Y. Chuang, W.-T. Lai, S.-H. Sheu

Mar 06
Issue: 1/2006
Oct 06
Issue: 3/2006

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits